| 摘要 |
Disclosed are various sustained release pharmaceutical compositions that include an agent that enhances or modulates the endogenous production of nitric oxide or insulin in a mammal. Sustained release pharmaceutical compositions of L-arginine, its salts, peptides, esters, and biological equivalents, together with methods of using the compositions are included. Also included are sustained release pharmaceutical compositions of botanical extracts that modulate or enhance the production of nitric oxide, or insulin , either alone or in combination with L-arginine or its biological equivalent.
|
